Jared Cox1, Christopher L Amling. 1. Department of Surgery/Division of Urology, University of Alabama at Birmingham, Alabama 35294, USA.
Abstract
PURPOSE OF REVIEW: Prostate cancer continues to be the most prevalent cancer among American men. Localized prostate cancer is commonly diagnosed because of improved screening practices nationwide. Several options exist for the treatment of localized prostate cancer, and this review discusses the decision-making process facing patients diagnosed with this disease. RECENT FINDINGS: No one treatment for localized prostate cancer has proven superior to date. For this reason patients have been found to use a number of resources to make an informed decision. These include physicians, spouses, family, friends, and different media. Urologists serve as the primary and most influential physicians and play an important role in the decision-making process. Patients, however, are assuming a more active role in this process as time evolves, especially with ease of access to multiple information resources. SUMMARY: In deciding on a treatment for localized prostate cancer, patients must weigh the risks and benefits of each option. Urologists must provide patients with up-to-date information on these options and be aware of the different influences that surround these men during the decision-making process.
PURPOSE OF REVIEW: Prostate cancer continues to be the most prevalent cancer among American men. Localized prostate cancer is commonly diagnosed because of improved screening practices nationwide. Several options exist for the treatment of localized prostate cancer, and this review discusses the decision-making process facing patients diagnosed with this disease. RECENT FINDINGS: No one treatment for localized prostate cancer has proven superior to date. For this reason patients have been found to use a number of resources to make an informed decision. These include physicians, spouses, family, friends, and different media. Urologists serve as the primary and most influential physicians and play an important role in the decision-making process. Patients, however, are assuming a more active role in this process as time evolves, especially with ease of access to multiple information resources. SUMMARY: In deciding on a treatment for localized prostate cancer, patients must weigh the risks and benefits of each option. Urologists must provide patients with up-to-date information on these options and be aware of the different influences that surround these men during the decision-making process.
Authors: Valdair F Muglia; Antonio C Westphalen; Zhen J Wang; John Kurhanewicz; Peter R Carroll; Fergus V Coakley Journal: AJR Am J Roentgenol Date: 2011-12 Impact factor: 3.959
Authors: Leonard G Gomella; Jianqing Lin; Jean Hoffman-Censits; Patricia Dugan; Fran Guiles; Costas D Lallas; Jaspreet Singh; Peter McCue; Timothy Showalter; Richard K Valicenti; Adam Dicker; Edouard J Trabulsi Journal: J Oncol Pract Date: 2010-11 Impact factor: 3.840
Authors: R B Hovey; K E S Cuthbertson; K A Birnie; J W Robinson; B C Thomas; H F Massfeller; J D Ruether; C Scott Journal: J Cancer Educ Date: 2012-06 Impact factor: 2.037
Authors: Hang-In Noh; Jong Min Lee; Young Ho Yun; Sang Yoon Park; Duk-Soo Bae; Joo-Hyun Nam; Chong Taik Park; Chi-Heum Cho; Su Yeon Kye; Yoon Jung Chang Journal: Support Care Cancer Date: 2009-01-27 Impact factor: 3.603
Authors: Sun Hee Rim; Ingrid J Hall; Megan E Fairweather; Catherine R Fedorenko; Donatus U Ekwueme; Judith Lee Smith; Ian M Thompson; Thomas E Keane; David F Penson; Carol M Moinpour; Steven B Zeliadt; Scott D Ramsey Journal: Int J Gen Med Date: 2011-06-17
Authors: Daphne Y Lichtensztajn; John T Leppert; James D Brooks; Sumit A Shah; Weiva Sieh; Benjamin I Chung; Scarlett L Gomez; Iona Cheng Journal: J Natl Compr Canc Netw Date: 2018-11 Impact factor: 12.693